PRA partners to boost recruitment in Latin America

By Nick Taylor

- Last updated on GMT

Related tags Pra

PRA International has entered into a partnership with Oncopartners and IBPC to accelerate the planning, start-up and patient recruitment of oncology trials in Latin America.

Boosting recruitment rates appeals to pharma companies, which, faced with the imminent patent cliff and cost-cutting, cannot afford delays in the drug development process.

To meet this demand contract research organisations (CRO) are turning to emerging markets. PRA is continuing this trend by entering into a partnership with Oncopartners, a Latin American oncology development company, and IBPC, a non-profit oncology research network.

IBPC’s network is comprised of Brazil’s largest public oncology hospitals. These treat an estimated 140,000 new incidences of cancer a year, giving PRA access to a large patient pool.

Oncopartners has worked previously with IBPC, building close relationships with member sites, investigators and research staff. PRA, and its sponsors, will now benefit from this established relationship by gaining access to the sites, expertise and patient pool.

Furthermore, PRA believes that it can make further cuts to developmental timelines by aligning its operational processes with Oncopartners. Establishing a close relationship between the three partners will potentially help streamline processes.

For example, PRA believes that centralised management of ethics committees, regulatory dossiers, study budget and contract management will accelerate study start-up.

This will be followed by rapid patient recruitment with high protocol compliance and data quality, according to PRA, and the trial will be conducted by “an internationally recognised team of medical and clinical oncology experts​”.

PRA and its partners have already begun this process, initiating start-up activities on two collaborative studies.

The partnership between PRA and Oncopartners also covers exclusive co-promotion and co-marketing of outsourced global oncology trials in the pre-award phase.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more